Borroni B - Search Results

1

Publisher Correction: Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target.

Borroni B, Stanic J, Verpelli C, Mellone M, Bonomi E, Alberici A, Bernasconi P, Culotta L, Zianni E, Archetti S, Manes M, Gazzina S, Ghidoni R, Benussi L, Stuani C, Di Luca M, Sala C, Buratti E, Padovani A, Gardoni F. Borroni B, et al. Sci Rep. 2018 Jan 5;8(1):272. doi: 10.1038/s41598-017-18750-8. Sci Rep. 2018. PMID: 29305592 Free PMC article.

2

Platelets as a peripheral district where to study pathogenetic mechanisms of alzheimer disease: the case of amyloid precursor protein.

Di Luca M, Colciaghi F, Pastorino L, Borroni B, Padovani A, Cattabeni F. Di Luca M, et al. Among authors: borroni b. Eur J Pharmacol. 2000 Sep 29;405(1-3):277-83. doi: 10.1016/s0014-2999(00)00559-8. Eur J Pharmacol. 2000. PMID: 11033334 Review.

3

Presenilin 2 mutation does not influence expression and concentration of APP forms in human platelets.

Pastorino L, Colciaghi F, Marcon G, Borroni B, Cottini E, Cattabeni F, Padovani A, Di Luca M. Pastorino L, et al. Among authors: borroni b. Mol Med. 2000 Oct;6(10):816-24. Mol Med. 2000. PMID: 11126197 Free PMC article.

4

Amyloid precursor protein in platelets of patients with Alzheimer disease: effect of acetylcholinesterase inhibitor treatment.

Borroni B, Colciaghi F, Pastorino L, Pettenati C, Cottini E, Rozzini L, Monastero R, Lenzi GL, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Arch Neurol. 2001 Mar;58(3):442-6. doi: 10.1001/archneur.58.3.442. Arch Neurol. 2001. PMID: 11255448 Clinical Trial.

5

Platelet amyloid precursor protein forms in AD: a peripheral diagnostic tool and a pharmacological target.

Padovani A, Borroni B, Colciaghi F, Pastorino L, Archetti S, Cottini E, Caimi L, Cattabeni F, Di Luca M. Padovani A, et al. Among authors: borroni b. Mech Ageing Dev. 2001 Nov;122(16):1997-2004. doi: 10.1016/s0047-6374(01)00315-3. Mech Ageing Dev. 2001. PMID: 11589917 Review.

6

Lemierre's syndrome complicated by carotid thrombosis.

Maalikjy Akkawi N, Borroni B, Magoni M, Vignolo LA, Padovani A. Maalikjy Akkawi N, et al. Among authors: borroni b. Neurol Sci. 2001 Oct;22(5):403-4. doi: 10.1007/s100720100073. Neurol Sci. 2001. PMID: 11917980

7

ApoE genotype influences the biological effect of donepezil on APP metabolism in Alzheimer disease: evidence from a peripheral model.

Borroni B, Colciaghi F, Pastorino L, Archetti S, Corsini P, Cattabeni F, Di Luca M, Padovani A. Borroni B, et al. Eur Neuropsychopharmacol. 2002 Jun;12(3):195-200. doi: 10.1016/s0924-977x(02)00013-5. Eur Neuropsychopharmacol. 2002. PMID: 12007670

8

[alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.

Colciaghi F, Borroni B, Pastorino L, Marcello E, Zimmermann M, Cattabeni F, Padovani A, Di Luca M. Colciaghi F, et al. Among authors: borroni b. Mol Med. 2002 Feb;8(2):67-74. Mol Med. 2002. PMID: 12080182 Free PMC article.

9

Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction.

Borroni B, Volpi R, Martini G, Del Bono R, Archetti S, Colciaghi F, Akkawi NM, Di Luca M, Romanelli G, Caimi L, Padovani A. Borroni B, et al. Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):150-5. doi: 10.1097/00002093-200207000-00004. Alzheimer Dis Assoc Disord. 2002. PMID: 12218645

10

Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.

Borroni B, Pettenati C, Bordonali T, Akkawi N, Di Luca M, Padovani A. Borroni B, et al. Neurosci Lett. 2003 Jun 12;343(3):213-5. doi: 10.1016/s0304-3940(03)00336-7. Neurosci Lett. 2003. PMID: 12770699 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

541 results

Search Page

Filters